Bolooki H
Med Instrum. 1986 Sep-Oct;20(5):266-76.
Although the initial clinical application of IABP was for the purpose of support of circulation in cardiogenic shock, its indications have expanded and include prophylactic use, especially in patients with ischemic heart disease. Controversy exists regarding the efficacy of this device in these conditions. Prolonged balloon support for periods of more than 5 days is presently employed in patients with chronic heart failure undergoing cardiac surgery, without concern for so-called "balloon dependence." In recent years, the incidence of use of IABP has declined markedly mainly because of comparable effects obtained by hemodynamic treatment with various drugs aimed at altering a specific parameter of cardiac function. Percutaneous application of an intra-aortic balloon catheter, although associated with a higher complication rate, has brought to clinical practice a rapid method for utilization of this device under fluoroscopic control. Because of an appreciable number of complications, however, balloon assist should be used for very specific clinical conditions.
尽管主动脉内球囊反搏（IABP）最初的临床应用是为了支持心源性休克患者的循环，但它的适应证已经扩大，包括预防性使用，尤其是在缺血性心脏病患者中。关于该装置在这些情况下的疗效存在争议。目前，慢性心力衰竭患者在接受心脏手术时，会使用球囊支持超过5天，而无需担心所谓的“球囊依赖”。近年来，IABP的使用发生率显著下降，主要是因为通过使用各种旨在改变心脏功能特定参数的药物进行血流动力学治疗可获得类似效果。经皮应用主动脉内球囊导管，尽管并发症发生率较高，但已在临床实践中带来了一种在荧光镜控制下快速使用该装置的方法。然而，由于并发症数量可观，球囊辅助应仅用于非常特定的临床情况。
